These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15378130

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W, Lopaschuk GD.
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [Abstract] [Full Text] [Related]

  • 25. Targets for modulation of fatty acid oxidation in the heart.
    Lopaschuk GD.
    Curr Opin Investig Drugs; 2004 Mar; 5(3):290-4. PubMed ID: 15083595
    [Abstract] [Full Text] [Related]

  • 26. Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia.
    Chavez PN, Stanley WC, McElfresh TA, Huang H, Sterk JP, Chandler MP.
    Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1521-7. PubMed ID: 12521928
    [Abstract] [Full Text] [Related]

  • 27. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
    Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC.
    J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
    [Abstract] [Full Text] [Related]

  • 28. Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.
    Grynberg A.
    Curr Pharm Des; 2005 Apr; 11(4):489-509. PubMed ID: 15725067
    [Abstract] [Full Text] [Related]

  • 29. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
    Ford WR, Lopaschuk GD, Schulz R, Clanachan AS.
    Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
    [Abstract] [Full Text] [Related]

  • 30. Cardiac metabolism in ischemic heart disease.
    Opie LH.
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [Abstract] [Full Text] [Related]

  • 31. Anti-anginal effects of partial fatty acid oxidation inhibitors.
    Lam A, Lopaschuk GD.
    Curr Opin Pharmacol; 2007 Apr; 7(2):179-85. PubMed ID: 17307396
    [Abstract] [Full Text] [Related]

  • 32. Efficacy of metabolic modulators in ischemic heart disease: an overview.
    Kalra BS, Roy V.
    J Clin Pharmacol; 2012 Mar; 52(3):292-305. PubMed ID: 21383339
    [Abstract] [Full Text] [Related]

  • 33. Computational studies of the effects of myocardial blood flow reductions on cardiac metabolism.
    Salem JE, Stanley WC, Cabrera ME.
    Biomed Eng Online; 2004 Jun 02; 3(1):15. PubMed ID: 15175110
    [Abstract] [Full Text] [Related]

  • 34. Ranolazine: new approach for the treatment of stable angina pectoris.
    Stanley WC.
    Expert Rev Cardiovasc Ther; 2005 Sep 02; 3(5):821-9. PubMed ID: 16181027
    [Abstract] [Full Text] [Related]

  • 35. Bioenergetics, ischemic contracture and reperfusion injury.
    Das DK, Maulik N.
    EXS; 1996 Sep 02; 76():155-73. PubMed ID: 8805794
    [Abstract] [Full Text] [Related]

  • 36. Metabolic and genetic regulation of cardiac energy substrate preference.
    Kodde IF, van der Stok J, Smolenski RT, de Jong JW.
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Jan 02; 146(1):26-39. PubMed ID: 17081788
    [Abstract] [Full Text] [Related]

  • 37. Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia.
    Zhou L, Huang H, McElfresh TA, Prosdocimo DA, Stanley WC.
    Am J Physiol Heart Circ Physiol; 2008 Sep 02; 295(3):H939-H945. PubMed ID: 18660443
    [Abstract] [Full Text] [Related]

  • 38. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov 02; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 39. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
    Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H, Sevostjanovs E, Grinberga S, Pugovics O, Dambrova M.
    Metabolism; 2014 Jan 02; 63(1):127-36. PubMed ID: 24140100
    [Abstract] [Full Text] [Related]

  • 40. Metabolic energy metabolism in diabetes: therapeutic implications.
    Pogatsa G.
    Coron Artery Dis; 2001 Feb 02; 12 Suppl 1():S29-33. PubMed ID: 11286305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.